Commonwealth Equity Services’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10K | Buy |
26,142
+30
| +0.1% | +$11 | ﹤0.01% | 4233 |
|
|
2025
Q1 | $27K | Buy |
26,112
+1,880
| +8% | +$1.94K | ﹤0.01% | 4110 |
|
|
2024
Q4 | $24K | Buy |
24,232
+120
| +0.5% | +$119 | ﹤0.01% | 4033 |
|
|
2024
Q3 | $35K | Sell |
24,112
-500
| -2% | -$726 | ﹤0.01% | 3962 |
|
|
2024
Q2 | $33K | Hold |
24,612
| – | – | ﹤0.01% | 3931 |
|
|
2024
Q1 | $40K | Buy |
24,612
+1,000
| +4% | +$1.63K | ﹤0.01% | 3917 |
|
|
2023
Q4 | $46K | Sell |
23,612
-750
| -3% | -$1.46K | ﹤0.01% | 3765 |
|
|
2023
Q3 | $58K | Sell |
24,362
-10
| -0% | -$24 | ﹤0.01% | 3643 |
|
|
2023
Q2 | $62K | Sell |
24,372
-140
| -0.6% | -$356 | ﹤0.01% | 3636 |
|
|
2023
Q1 | $39 | Buy |
24,512
+8,499
| +53% | +$14 | ﹤0.01% | 3609 |
|
|
2022
Q4 | $43K | Buy |
16,013
+11,712
| +272% | +$31.5K | ﹤0.01% | 3528 |
|
|
2022
Q3 | $16K | Buy |
4,301
+3,014
| +234% | +$11.2K | ﹤0.01% | 3598 |
|
|
2022
Q2 | $7K | Sell |
1,287
-95
| -7% | -$517 | ﹤0.01% | 3639 |
|
|
2022
Q1 | $15K | Sell |
1,382
-80
| -5% | -$868 | ﹤0.01% | 3671 |
|
|
2021
Q4 | $21K | Buy |
1,462
+392
| +37% | +$5.63K | ﹤0.01% | 3597 |
|
|
2021
Q3 | $32K | Sell |
1,070
-150
| -12% | -$4.49K | ﹤0.01% | 3526 |
|
|
2021
Q2 | $56K | Buy |
+1,220
| New | +$56K | ﹤0.01% | 3455 |
|